222 related articles for article (PubMed ID: 27115492)
1. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
[TBL] [Abstract][Full Text] [Related]
2. A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale.
Zhao L; Cavallaro AS; Wibowo D; Zhang B; Zhang J; Mitter N; Yu C; Zhao CX; Middelberg AP
Vaccine; 2017 Jan; 35(1):77-83. PubMed ID: 27890399
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
[TBL] [Abstract][Full Text] [Related]
4. Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.
Albarrak SM; Brown WC; Noh SM; Reif KE; Scoles GA; Turse JE; Norimine J; Ueti MW; Palmer GH
PLoS One; 2012; 7(9):e46372. PubMed ID: 23029498
[TBL] [Abstract][Full Text] [Related]
5. Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.
Ducken DR; Brown WC; Alperin DC; Brayton KA; Reif KE; Turse JE; Palmer GH; Noh SM
PLoS One; 2015; 10(6):e0129309. PubMed ID: 26079491
[TBL] [Abstract][Full Text] [Related]
6. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
Araújo FR; Costa CM; Ramos CA; Farias TA; Souza II; Melo ES; Elisei C; Rosinha GM; Soares CO; Fragoso SP; Fonseca AH
Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):186-90. PubMed ID: 18425271
[TBL] [Abstract][Full Text] [Related]
7. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule.
Silvestre BT; Rabelo ÉM; Versiani AF; da Fonseca FG; Silveira JA; Bueno LL; Fujiwara RT; Ribeiro MF
Vaccine; 2014 Apr; 32(19):2160-6. PubMed ID: 24606864
[TBL] [Abstract][Full Text] [Related]
9. Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge.
Noh SM; Turse JE; Brown WC; Norimine J; Palmer GH
Clin Vaccine Immunol; 2013 May; 20(5):651-6. PubMed ID: 23446216
[TBL] [Abstract][Full Text] [Related]
10. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
Sarli M; Novoa MB; Mazzucco MN; Signorini ML; Echaide IE; de Echaide ST; Primo ME
PLoS One; 2020; 15(2):e0229301. PubMed ID: 32084216
[TBL] [Abstract][Full Text] [Related]
11. Cloning, sequencing and antigenic characterization of rVirB9 of Anaplasma marginale isolated from Paraná State, Brazil.
Vidotto MC; Venâncio EJ; Vidotto O
Genet Mol Res; 2008; 7(2):460-6. PubMed ID: 18561379
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.
Nuñez PA; Moretta R; Ruybal P; Wilkowsky S; Farber MD
Curr Microbiol; 2014 Mar; 68(3):269-77. PubMed ID: 24126603
[TBL] [Abstract][Full Text] [Related]
13. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge.
Brown WC; Shkap V; Zhu D; McGuire TC; Tuo W; McElwain TF; Palmer GH
Infect Immun; 1998 Nov; 66(11):5406-13. PubMed ID: 9784551
[TBL] [Abstract][Full Text] [Related]
15. Induced immune response of DNA vaccine encoding an association MSP1a, MSP1b, and MSP5 antigens of Anaplasma marginale.
Kano FS; Tamekuni K; Coelho AL; Garcia JL; Vidotto O; Itano EN; Vidotto MC
Vaccine; 2008 Jun; 26(27-28):3522-7. PubMed ID: 18502005
[TBL] [Abstract][Full Text] [Related]
16. Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice.
Santos PS; Sena AA; Nascimento R; Araújo TG; Mendes MM; Martins JR; Mineo TW; Mineo JR; Goulart LR
PLoS One; 2013; 8(4):e60311. PubMed ID: 23579784
[TBL] [Abstract][Full Text] [Related]
17. Cloning, sequencing, expression, and antigenic characterization of rMSP4 from Anaplasma marginale isolated from Paraná State, Brazil.
Kawasaki PM; Kano FS; Vidotto O; Vidotto MC
Genet Mol Res; 2007 Jan; 6(1):15-22. PubMed ID: 17278086
[TBL] [Abstract][Full Text] [Related]
18. Anaplasma marginale outer membrane protein vaccine candidates are conserved in North American and South African strains.
Hove P; Brayton KA; Liebenberg J; Pretorius A; Oosthuizen MC; Noh SM; Collins NE
Ticks Tick Borne Dis; 2020 Jul; 11(4):101444. PubMed ID: 32336660
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to Anaplasma marginale major surface proteins 1a and 1b inhibit infectivity for cultured tick cells.
Blouin EF; Saliki JT; de la Fuente J; Garcia-Garcia JC; Kocan KM
Vet Parasitol; 2003 Feb; 111(2-3):247-60. PubMed ID: 12531299
[TBL] [Abstract][Full Text] [Related]
20. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation.
Lopez JE; Beare PA; Heinzen RA; Norimine J; Lahmers KK; Palmer GH; Brown WC
J Immunol Methods; 2008 Mar; 332(1-2):129-41. PubMed ID: 18243240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
